132 related articles for article (PubMed ID: 38869005)
21. Implementing a framework for integrating toxicokinetics into human health risk assessment for agrochemicals.
Terry C; Hays S; McCoy AT; McFadden LG; Aggarwal M; Rasoulpour RJ; Juberg DR
Regul Toxicol Pharmacol; 2016 Mar; 75():89-104. PubMed ID: 26472101
[TBL] [Abstract][Full Text] [Related]
22. The Future of Uncertainty Factors With In Vitro Studies Using Human Cells.
Dourson M; Ewart L; Fitzpatrick SC; Barros SBM; Mahadevan B; Hayes AW
Toxicol Sci; 2022 Feb; 186(1):12-17. PubMed ID: 34755872
[TBL] [Abstract][Full Text] [Related]
23. Using toxicokinetic-toxicodynamic modeling as an acute risk assessment refinement approach in vertebrate ecological risk assessment.
Ducrot V; Ashauer R; Bednarska AJ; Hinarejos S; Thorbek P; Weyman G
Integr Environ Assess Manag; 2016 Jan; 12(1):32-45. PubMed ID: 25833822
[TBL] [Abstract][Full Text] [Related]
24. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
Chou WC; Lin Z
Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
[TBL] [Abstract][Full Text] [Related]
25. Highly time-variable exposure to chemicals--toward an assessment strategy.
Ashauer R; Brown CD
Integr Environ Assess Manag; 2013 Jul; 9(3):e27-33. PubMed ID: 23564608
[TBL] [Abstract][Full Text] [Related]
26. Analysis for data-derived extrapolation factors for procymidone.
Gadagbui BK; York RG; Dourson ML; McGinnis PM; Cope RB
Regul Toxicol Pharmacol; 2021 Aug; 124():104972. PubMed ID: 34119600
[TBL] [Abstract][Full Text] [Related]
27. Advancing probabilistic risk assessment by integrating human biomonitoring, new approach methods, and Bayesian modeling: A case study with the mycotoxin deoxynivalenol.
Lu EH; Grimm FA; Rusyn I; De Saeger S; De Boevre M; Chiu WA
Environ Int; 2023 Dec; 182():108326. PubMed ID: 38000237
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP).
Jarabek AM; Asgharian B; Miller FJ
Inhal Toxicol; 2005; 17(7-8):317-34. PubMed ID: 16020031
[TBL] [Abstract][Full Text] [Related]
29. Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos.
Poet TS; Timchalk C; Bartels MJ; Smith JN; McDougal R; Juberg DR; Price PS
Regul Toxicol Pharmacol; 2017 Jun; 86():59-73. PubMed ID: 28238854
[TBL] [Abstract][Full Text] [Related]
30. In Vitro- in Vivo Extrapolation of Hepatic Metabolism for Different Scenarios - a Toolbox.
Krause S; Goss KU
Chem Res Toxicol; 2018 Nov; 31(11):1195-1202. PubMed ID: 30259739
[TBL] [Abstract][Full Text] [Related]
31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
32. Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation.
Walton K; Dorne JL; Renwick AG
Food Chem Toxicol; 2001 Dec; 39(12):1175-90. PubMed ID: 11696391
[TBL] [Abstract][Full Text] [Related]
33. Predicting the Metal Mixture Toxicity with a Toxicokinetic-Toxicodynamic Model Considering the Time-Dependent Adverse Outcome Pathways.
Yang L; Zeng J; Gao N; Zhu L; Feng J
Environ Sci Technol; 2024 Feb; 58(8):3714-3725. PubMed ID: 38350648
[TBL] [Abstract][Full Text] [Related]
34. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.
Dorne JL; Renwick AG
Toxicol Sci; 2005 Jul; 86(1):20-6. PubMed ID: 15800035
[TBL] [Abstract][Full Text] [Related]
35. Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics.
Jeong SH; Jang JH; Lee YB
Environ Pollut; 2022 Nov; 312():120041. PubMed ID: 36030954
[TBL] [Abstract][Full Text] [Related]
36. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
37. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of locally naturalized Panicum species to HPPD- and ALS-inhibiting herbicides in maize.
De Cauwer B; Geeroms T; Claerhout S; Reheul D; Bulcke R
Commun Agric Appl Biol Sci; 2012; 77(3):353-61. PubMed ID: 23878990
[TBL] [Abstract][Full Text] [Related]
39. Physiological and Molecular Mechanisms of Differential Sensitivity of Palmer Amaranth (Amaranthus palmeri) to Mesotrione at Varying Growth Temperatures.
Godar AS; Varanasi VK; Nakka S; Prasad PV; Thompson CR; Mithila J
PLoS One; 2015; 10(5):e0126731. PubMed ID: 25992558
[TBL] [Abstract][Full Text] [Related]
40. Improving the Herbicide Resistance of Rice 4-Hydroxyphenylpyruvate Dioxygenase by DNA Shuffling Basis-Directed Evolution.
Chen L; Liu R; Tan Q; Luo H; Chen Y; Jin Y; Zheng Z; Zhang B; Guo D
J Agric Food Chem; 2023 Oct; 71(41):15186-15193. PubMed ID: 37788677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
